NICE approves combination therapy for hepatitis C

Combination drugs for hepatitis C have been recommended by the National Institute for Clinical Excellence. NICE said that patients suffering from moderate or severe hepatitis C should be given a combination of the drugs interferon alpha and ribavirin. Until June 1999, interferon alpha was the only licensed treatment for chronic ...

You need to be signed in to read more

HSJ

Subscribe for unlimited access

With a HSJ subscription you’ll unlock:

  • All of HSJ.co.uk and our HSJ mobile app
  • News and insight on all areas of public funded healthcare
  • Expert commentary, insight and analysis from industry leaders
  • 9 weekly ‘Expert Briefing’ insight emails covering a variety of specialist topics

Sign into your account here